These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 21422389)

  • 1. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.
    Kolandaivelu K; Swaminathan R; Gibson WJ; Kolachalama VB; Nguyen-Ehrenreich KL; Giddings VL; Coleman L; Wong GK; Edelman ER
    Circulation; 2011 Apr; 123(13):1400-9. PubMed ID: 21422389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter by Vorpahl and Kelm regarding article, "Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings".
    Vorpahl M; Kelm M
    Circulation; 2011 Nov; 124(19):e511; author reply e512. PubMed ID: 22064963
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
    Otsuka F; Cheng Q; Yahagi K; Acampado E; Sheehy A; Yazdani SK; Sakakura K; Euller K; Perkins LEL; Kolodgie FD; Virmani R; Joner M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1248-1260. PubMed ID: 26292590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
    Sperling C; Waliszewski MW; Kherad B; Krackhardt F
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Evaluation of Vessel HEaling After AngiopLasty (REVEAL) trial: rationale, objectives and design.
    Tamburino C; Capodanno D; La Manna A; di Salvo M; Sanfilippo A; Prati F
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):53-8. PubMed ID: 19829136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombogenicity and early vascular healing response in metallic biodegradable polymer-based and fully bioabsorbable drug-eluting stents.
    Koppara T; Cheng Q; Yahagi K; Mori H; Sanchez OD; Feygin J; Wittchow E; Kolodgie FD; Virmani R; Joner M
    Circ Cardiovasc Interv; 2015 Jun; 8(6):e002427. PubMed ID: 26022535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction.
    Räber L; Yamaji K; Kelbæk H; Engstrøm T; Baumbach A; Roffi M; von Birgelen C; Taniwaki M; Moschovitis A; Zaugg S; Ostojic M; Pedrazzini G; Karagiannis-Voules DA; Lüscher TF; Kornowski R; Tüller D; Vukcevic V; Heg D; Windecker S
    Eur Heart J; 2019 Jun; 40(24):1909-1919. PubMed ID: 30851032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
    Taniwaki M; Radu MD; Zaugg S; Amabile N; Garcia-Garcia HM; Yamaji K; Jørgensen E; Kelbæk H; Pilgrim T; Caussin C; Zanchin T; Veugeois A; Abildgaard U; Jüni P; Cook S; Koskinas KC; Windecker S; Räber L
    Circulation; 2016 Feb; 133(7):650-60. PubMed ID: 26762519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of blood-material interaction and drug eluting stent polymers in review.
    Mori H; Gupta A; Torii S; Harari E; Jinnouchi H; Virmani R; Finn AV
    Expert Rev Med Devices; 2017 Sep; 14(9):707-716. PubMed ID: 28770625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early coverage of drug-eluting stents analysed by optical coherence tomography: evidence of the impact of stent apposition and strut characteristics on the neointimal healing process.
    Lee R; Foin N; Ng J; Allen J; Soh N; Ang I; Shim W; Torii R; Wong P
    EuroIntervention; 2016 Aug; 12(5):e605-14. PubMed ID: 27497360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents.
    Gasior P; Lu S; Ng CKJ; Toong WYD; Wong EHP; Foin N; Kedhi E; Wojakowski W; Ang HY
    Sci Rep; 2020 Nov; 10(1):20791. PubMed ID: 33247219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis and drug-eluting stents: a critical appraisal.
    Kereiakes DJ; Choo JK; Young JJ; Broderick TM
    Rev Cardiovasc Med; 2004; 5(1):9-15. PubMed ID: 15029110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable polymer-coated thin strut sirolimus-eluting stent vs durable polymer-coated everolimus-eluting stent in daily clinical practice: Propensity matched one-year results from interventional cardiology network registry.
    Gasior P; Gierlotka M; Szczurek-Katanski K; Osuch M; Gnot R; Hawranek M; Gasior M; Polonski L
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):E362-E368. PubMed ID: 30298545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin, Very Thin, or Ultrathin Strut Biodegradable or Durable Polymer-Coated Drug-Eluting Stents: 3-Year Outcomes of BIO-RESORT.
    Buiten RA; Ploumen EH; Zocca P; Doggen CJM; Danse PW; Schotborgh CE; Scholte M; van Houwelingen KG; Stoel MG; Hartmann M; Tjon Joe Gin RM; Somi S; Linssen GCM; Kok MM; von Birgelen C
    JACC Cardiovasc Interv; 2019 Sep; 12(17):1650-1660. PubMed ID: 31422087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
    von Birgelen C; Kok MM; van der Heijden LC; Danse PW; Schotborgh CE; Scholte M; Gin RMTJ; Somi S; van Houwelingen KG; Stoel MG; de Man FHAF; Louwerenburg JHW; Hartmann M; Zocca P; Linssen GCM; van der Palen J; Doggen CJM; Löwik MM
    Lancet; 2016 Nov; 388(10060):2607-2617. PubMed ID: 27806902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Current Literature on Bioabsorbable Stents: a Review.
    Omar WA; Kumbhani DJ
    Curr Atheroscler Rep; 2019 Nov; 21(12):54. PubMed ID: 31768641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.